Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States

Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling

(2021) Carleen Klumpp-Thomas et al.   Nature Communications

Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series

(2021) Thao T. Truong et al.   EBioMedicine

Adjusted logistic propensity weighting methods for population inference using nonprobability volunteer‐based epidemiologic cohorts

(2021) Lingxiao Wang et al.   STATISTICS IN MEDICINE

An interactive web-based dashboard to track COVID-19 in real time

(2020) Ensheng Dong et al.   LANCET INFECTIOUS DISEASES

Covid-19 — Navigating the Uncharted

(2020) Anthony S. Fauci et al.   NEW ENGLAND JOURNAL OF MEDICINE

Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020

(2020) Neeraj Sood et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho

(2020) Andrew Bryan et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A human neutralizing antibody targets the receptor binding site of SARS-CoV-2

(2020) Rui Shi et al.   NATURE

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

(2020) Dora Pinto et al.   NATURE

Antibody responses to SARS-CoV-2 in patients with COVID-19

(2020) Quan-Xin Long et al.   NATURE MEDICINE

Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19

(2020) Mandeep R. Mehra et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control

(2020) Cheryl Yi-Pin Lee et al.   Frontiers in Immunology

Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis

(2020) Panagiota I. Kontou et al.   Diagnostics

Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York

(2020) Eli S. Rosenberg et al.   ANNALS OF EPIDEMIOLOGY

Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications

(2020) Saverio Caini et al.   Eurosurveillance

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

(2020) Lihong Liu et al.   NATURE

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

(2020) Xiangyang Chi et al.   SCIENCE

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis

(2020) Mayara Lisboa Bastos et al.   BMJ-British Medical Journal

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020

(2020) Fiona P. Havers et al.   JAMA Internal Medicine

Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties, April 28–May 3, 2020

(2020) Holly M. Biggs et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020

(2020) Nir Menachemi et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Notes from the Field: Seroprevalence Estimates of SARS-CoV-2 Infection in Convenience Sample — Oregon, May 11–June 15, 2020

(2020) Melissa Sutton et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis

(2020) A. Rostami et al.   CLINICAL MICROBIOLOGY AND INFECTION

Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study

(2020) Shuchi Anand et al.   LANCET

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

(2020) Mark Ainsworth et al.   LANCET INFECTIOUS DISEASES

Optimizing high-yield production of SARS-CoV-2 soluble spike trimers for serology assays

(2020) Dominic Esposito et al.   PROTEIN EXPRESSION AND PURIFICATION

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

(2020) Angkana T. Huang et al.   Nature Communications

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood

(2020) Dianna L. Ng et al.   Nature Communications

COVID-19 Trends Among School-Aged Children — United States, March 1–September 19, 2020

(2020) Rebecca T. Leeb et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Effect of D614G Spike Variant on Immunoglobulin G, M, or A Spike Seroassay Performance

(2020) Carleen Klumpp-Thomas et al.   JOURNAL OF INFECTIOUS DISEASES

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020

(2020) Kristina L. Bajema et al.   JAMA Internal Medicine

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays

(2020) Jennifer Mehalko et al.   PROTEIN EXPRESSION AND PURIFICATION

Inference for Nonprobability Samples

(2017) Michael R. Elliott et al.   STATISTICAL SCIENCE

Combining one-sample confidence procedures for inference in the two-sample case

(2014) Michael P. Fay et al.   BIOMETRICS

The Pathology of Influenza Virus Infections

(2008) Jeffery K. Taubenberger et al.   Annual Review of Pathology-Mechanisms of Disease